Medical Journals

Runx1-runx1 Homodimerization Modulates Runx1 Activity and Function.

Authors:
  • Li Donglan
  • Sinha Kislay K
  • Hay Maher A
  • Rinaldi Ciro R
  • Saunthararajah Yogen
  • Nucifora Giuseppina

From: Department of Medicine, University of Illinois, Chicago, Illinois 60612, USA.

The Journal of biological chemistry

  • Publish Date: May 2007
  • ISSN: 0021-9258
  • Volume: 282
  • Issue: 18
  • Pages: 13542-51
  • Medium: Print
  • Language: English
  • Citation (JAMA): Li Donglan, Sinha Kislay K, Hay Maher A, et al. Runx1-runx1 Homodimerization Modulates Runx1 Activity and Function.. J. Biol. Chem. May 2007;282:13542-51

Abstract

RUNX1 (AML1, CBFalpha2, PEBP2alphaB) is a transcription factor essential for the establishment of the hematopoietic stem cell. It is generally thought that RUNX1 exists as a monomer that regulates hematopoietic differentiation by interacting with tissue-specific factors and its DNA consensus through its N terminus. RUNX1 is frequently altered in human leukemia by gene fusions or point mutations. In general, these alterations do not affect the N terminus of the protein, and it is unclear how they consistently lead to hematopoietic transformation and leukemia. Here we report that RUNX1 homodimerizes through a mechanism involving C terminus-C terminus interaction. This RUNX1-RUNX1 interaction regulates the activity of the protein in reporter gene assays and modulates its ability to induce hematopoietic differentiation of hematopoietic cell lines. The promoters of genes regulated by RUNX1 often contain multiple RUNX1 binding sites. This arrangement suggests that RUNX1 could homodimerize to bring and hold together distant chromatin sites and factors and that if the dimerization region is removed by gene fusions or is altered by point mutations, as observed in leukemia, the ability of RUNX1 to regulate differentiation could be impaired.

Mesh Headings (Keywords): Animals, Binding Sites, Cell Differentiation, Cell Transformation, Neoplastic, Core Binding Factor Alpha 2 Subunit, Dimerization, Gene Expression Regulation, Hela Cells, Hematopoietic Stem Cells, Humans, Leukemia, Mice, NIH 3T3 Cells, Oncogene Proteins, Fusion, Point Mutation, Protein Binding, Protein Structure, Tertiary, Response Elements


Check for Full Text / PubMed Unique Identifier (PMID): 17355962


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.